Ropes & Gray represented healthcare investment fund GHO Capital and portfolio company DNA Diagnostics Center in the sale of DNA Diagnostics to Eurofins, a publicly traded global laboratory testing business. The transaction was announced on June 28.
DNA Diagnostics Center is a leading consumer-focused DNA testing company producing DNA lab and testing services in sectors including family relationships, immigration, gender, fertility and healthcare. Its leading consumer brands include SpermCheck, HomePaternity and Peekaboo Early Gender Detection. The transaction will expand the position of Eurofins into the consumer genetics and health and wellness markets.
The Ropes & Gray team was led by private equity partners Tim Castelli and Neill Jakobe and private equity associate Andrew Pomranke (all of Chicago) and included IP litigation partner Jim Davis (Silicon Valley), tax partner Elaine Murphy (Boston), litigation & enforcement partners Tim Farrell (Chicago) and Samer Musallam (Washington, D.C.), health care partner Christina Bergeron (Boston), employment & benefits partner Jennifer Cormier (Boston) and IP transactions counsel Thomas Burke (New York).
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.